Interaction Guide · Research summary

Can I take Psyllium Husk Powder with Hydromorphone?

Review Psyllium Husk Powder with Hydromorphone: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Psyllium husk has general precautions about delaying oral medicine absorption, but reduced hydromorphone absorption or pain relief has not been established. Injected hydromorphone bypasses this intestinal absorption issue.

What this answer covers

Plantago ovata husk powder, not every fiber type; oral versus injected hydromorphone.

Supplement or preparation
Psyllium Husk Powder
Medication ingredient
hydromorphone

Delay is different from reduced absorption

The husk monograph warns that other oral medicines may be absorbed more slowly. It does not demonstrate less total hydromorphone absorbed or weaker pain relief.

Use the fiber’s actual directions

The EMA monograph advises a half-to-one-hour gap from other medicines and adequate liquid. This general instruction is not a hydromorphone-specific protective interval; ask the pharmacist to reconcile the actual products.

The route matters

An intestinal absorption concern cannot be assigned to intravenous, intramuscular or subcutaneous hydromorphone. Extended-release tablets also have their own instructions and must remain intact.

Constipation needs its own assessment

Hydromorphone may cause severe constipation. Before adding bulk fiber for persistent symptoms, discuss the bowel plan with the clinician. A spacing rule does not make a fiber product suitable in every gastrointestinal situation.

Evidence and practical considerations

Absorption & effectiveness

General husk delayed-absorption precaution does not prove reduced total oral hydromorphone exposure/efficacy and cannot apply to injected drug absorption.

Exact scope
Plantago ovata husk powder, not every fiber type; oral versus injected hydromorphone. with Hydromorphone RxCUI3423 IN; HCl oral immediate-release, extended-release and injected products distinguished.
Medication form and route
oral medication; intravenous medication; intramuscular medication; subcutaneous medication; oral supplement

What remains uncertain

  • No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.

Factors that may matter: Preparation; Dose; Other medicines; Organ function.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed hydromorphone

Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.

How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.

No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed hydromorphone

Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.

How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.

No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.

Source 3: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed hydromorphone

Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.

How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.

No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.

Source 4: regulatory herbal monograph

ema.europa.eu · Source check Sep 10, 2026

Population: Users of ispaghula husk preparations

Adequate liquid; half-to-one-hour separation from other medicines due to possible absorption delay. Medical supervision in diabetes because treatment adjustment may be necessary.

How this applies: Original source interpreted for hydromorphone only within the stated preparation and endpoint limits.

General oral-medicine absorption delay, not reduced total hydromorphone absorption or effectiveness. Does not apply to absorption of injected hydromorphone.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact hydromorphone article with formulation-specific evidence and uncertainty.
Research summary published

Article revision: 61e4b141021c6f2c

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.